Lainie P. Martin, MD, Antibody-Drug Conjugates and Ovarian Cancer

Posted: Thursday, February 6, 2025

Lainie P. Martin, MD, of Penn Medicine, Hospital of the University of Pennsylvania, briefly discusses the safety profile of antibody-drug conjugates used to treat ovarian cancer, particularly in comparison with the toxicities linked to combination platinum-based regimens, and shares best strategies for mitigating common adverse events with these newer agents.

---